Marginal Zone Lymphoma in a Case of Hidradenitis Suppurativa Treated With Adalimumab Therapy

被引：0

作者：

Shrestha, Anish ^{[1
]}

Pokherel, Rojina ^{[1
]}

Gaddipati, Greeshma ^{[1
]}

Desai, Pankti ^{[2
]}

机构：

[1] MedStar Hlth Internal Med Residency Program, Dept Internal Med, Baltimore, MD 21237 USA

[2] MedStar Hlth Franklin Sq Med Ctr, Dept Internal Med, Baltimore, MD 21237 USA

来源：

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES | 2025年 / 15卷 / 01期

关键词：

Hidradenitis suppurativa; Marginal zone lymphoma; TNF-alpha; Adalimumab;

D O I：

10.55729/2000-9666.1444

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Marginal zone lymphoma has seldom been described in relation to adalimumab used for treatment of hidradenitis suppurativa. Although studies have shown an increased risk of lymphoma with adalimumab, most of these studies were done in patients with underlying inflammatory bowel disease or rheumatoid arthritis where the disease itself presents as a confounder for lymphoma. Our case described adds to the role of chronic anti-TNF alpha therapy as a possible etiology of lymphoma.

引用

页数：6

共 14 条

[1] Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
Calip, Gregory S.
Patel, Pritesh R.
Adimadhyam, Sruthi
Xing, Shan
Wu, Zhaoju
Sweiss, Karen
Schumock, Glen T.
Lee, Todd A.
Chiu, Brian C. -H.
[J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (05) : 1062 - 1071
[2] Marginal zone lymphoma: present status and future perspectives
Cheah, Chan Y.
Zucca, Emanuele
Rossi, Davide
Habermann, Thomas M.
[J]. HAEMATOLOGICA, 2022, 107 (01) : 35 - 43
[3] Hidradenitis suppurativa: Disease pathophysiology and sex hormones
Chia-Bao Chu
Chao-Chun Yang
Shaw-Jenq Tsai
[J]. CHINESE JOURNAL OF PHYSIOLOGY, 2021, 64 (06): : 257 - 265
[4] Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
Dahmus, Jessica
Rosario, Michelle
Clarke, Kofi
[J]. CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 339 - 350
[5] Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors
Ferrer-Marin, Francisca
Luz Amigo, Maria
Vicente, Vicente
[J]. CLINICAL DRUG INVESTIGATION, 2012, 32 (06) : 423 - 426
[6] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan
Hayashi, Nobukazu
Hayama, Koremasa
Takahashi, Kenzo
Kurokawa, Ichiro
Okazaki, Masateru
Kashiwagi, Tomoko
Iwashita, Eri
Terui, Tadashi
[J]. JOURNAL OF DERMATOLOGY, 2022, 49 (04) : 411 - 421
[7] Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm
Jafari, S. Morteza Seyed
Hunger, Robert E.
Schlapbach, Christoph
[J]. FRONTIERS IN MEDICINE, 2020, 7
[8] Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, Alexa B.
Okun, Martin M.
Williams, David A.
Gottlieb, Alice B.
Papp, Kim A.
Zouboulis, Christos C.
Armstrong, April W.
Kerdel, Francisco
Gold, Michael H.
Forman, Seth B.
Korman, Neil J.
Giamarellos-Bourboulis, Evangelos J.
Crowley, Jeffrey J.
Lynde, Charles
Reguiai, Ziad
Prens, Errol-Prospero
Alwawi, Eihab
Mostafa, Nael M.
Pinsky, Brett
Sundaram, Murali
Gu, Yihua
Carlson, Dawn M.
Jemec, Gregor B. E.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (05) : 422 - 434
[9] Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
Mariette, X.
Tubach, F.
Bagheri, H.
Bardet, M.
Berthelot, J. M.
Gaudin, P.
Heresbach, D.
Martin, A.
Schaeverbeke, T.
Salmon, D.
Lemann, M.
Hermine, O.
Raphael, M.
Ravaud, P.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) : 400 - 408
[10] Menter T, 2017, AM J CLIN PATHOL, V147, P292, DOI [10.1093/AJCP/AQW208, 10.1093/ajcp/aqw208]

← 1 2 →